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Introduction
Hepatocellular carcinoma (HCC) is the fifth most prevalent cancer in the world and is associated with poor survival rates (1) . It commonly develops in the background of chronic hepatitis, particularly with hepatitis B or C virus infection (2, 3) . Nuclear factor-kappa B (NF-κB) is a transcription factor that plays critical roles in cell survival, proliferation, inflammation and the immune response against viral infections (4) (5) (6) . It has been reported that abnormal hyperactivation of NF-κB signaling pathway plays important roles in HCC progression (7, 8) .
The NF-κB family of dimeric transcription factors comprises seven proteins: RelA (p65), RelB, c-Rel, NF-κB1 (p105 and p50) and NF-κB2 (p100 and p52). In unstimculated cells, NF-κB dimers are sequestered in the cytoplasm by a family of inhibitors, known as the inhibitors of NF-κB (IκBs), consisting of IκB-α, IκB-β, IκB-ε, IκB-ζ and Bcl-3. In responding to various stimuli, the IκB kinase (IKK) phosphorylates IκB proteins, resulting in phosphorylation-induced ubiquitination and degradation of the IκB proteins. Consequently, NF-κB is liberated and translocates to the nucleus to activate the transcription of target genes. It is clear that IKK activation is an essential step in the pathway leading to NF-κB activation and that IKK-β, a subunit of IKK, is the predominant kinase in the canonical NF-κB pathway (9, 10) .
Recent advances in micro RNA (miRNA) research have provided new insights into the mechanisms driving HCC. miRNAs are a group of small non-coding RNAs (19-22 nucleotides) involved in regulating gene expression at the posttranscriptional level (11, 12) . Numerous studies have demonstrated that miRNAs play critical roles in multiple physiological processes, such as cellular proliferation, differentiation, apoptosis and tissue development (11, 12) . Accumulating evidence has provided that miRNAs are involved in the development of different types of human cancers, and they have been widely proposed as potential targets for anticancer therapies (13) (14) (15) (16) . Recently, multiple miRNAs have been shown to be implicated in HCC progression, such as miR-101 (17) , miR-126 (18) , miR-143 (19) , miR-145 (20, 21) , miR-185 (18) , miR-199b (21, 22) , miR-221 (22) , miR-223 (22) and miR-224 (21) . By analyzing a published microarray-based high-throughput screen, we found that miR-451 expression was significantly lower in HCC tissues than in matched non-cancerous liver tissues. Further study revealed that miR-451 deregulation correlates with proliferation in HCC cell lines. Using bioinformatics, we identified IKK-β as a potential direct target of miR-451. Thus, we decided to investigate the role of this miRNA and its relationship with the IKK-β-dependent NF-κB pathway in HCC tumorigenesis.
In this study, we found that miR-451 strongly repressed HCC proliferation by direct targeting the 3′-untranslated region (3′UTR) of IKBKB messenger RNA (mRNA), thus inhibiting the NF-κB pathway and downregulating cell cycle regulators, cyclin D1 and c-Myc, leading to G 1 /S arrest of HCC cells. Our results suggest that downregulation of miR-451 may be important for the development and progression of HCC, thus highlighting it as a potential target for human HCC therapy.
Materials and methods

Ethics statement
Prior written consent was obtained from patients and approval for the use of clinical materials for research purposes was obtained from the Sun YatSen University and First Affiliated Hospital Institutional Ethical Board. The eight HCC tissues and adjacent non-cancerous tissues used in this study were obtained from patients who underwent radical operations at the First Affiliated Hospital of Sun Yat-Sen University.
Cell culture
The HCC cell lines, BEL-7402, HCCC-9810, Hep3B, HepG2, HuH7, MHCC97-L, MHCC97-H and QGY-7703, were grown in Dulbecco's modified Eagle medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (HyClone, Logan, UT) and 1% penicillin/streptomycin. Immortalized normal liver epithelial cells, THLE3, were maintained in bronchial epithelial growth medium (Clonetics Corporation, Walkersville, MD), supplemented with 5 ng/ml epithelial growth factor, 70 ng/ml phosphoethanolamine and 10% fetal bovine serum. All cells were maintained in a humidified atmosphere at 37°C under 5% CO 2 .
RNA extraction, reverse transcription and real-time reverse transcriptionpolymerase chain reaction
Total RNA from cultured cells was extracted using the TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Complementary DNAs were amplified and quantified using the ABI Prism 7500 Sequence Detection System (Applied Biosystems, Foster City, CA) H.-P.Li et al.
using SYBR Green I dye (Molecular Probes, Invitrogen). The following primers were used: cyclin D1 forward, 5′-TCCTCTCCAAAATGCCA  GAG-3′;  cyclin  D1  reverse,  5′-GGCGGATTGG  AAATGAACTT-3′; MYC forward, 5′-TCAAGAGGCGAACACACAAC-3′;  MYC reverse, 5′-GGCCTTTTCATTGTTTTCCA-3′; bcl-xL forward,  5′-TCCTTGTCTACGCTTTCCACG-3′; bcl-xL reverse, 5′-GGTCGCATTGTG  GCCTTT-3′; IL8 forward, 5′-TGCCAAGGAGTGCTA AAG-3′; IL8 reverse,  5′-CTCCACAACCCTCTGCAC-3′; A20 forward, 5′-GGACTTTGCG  AAAGGATCG-3′; A20 reverse, 5′-TCACAGCTTTCCGCATATTG-3′; NFKBIA forward, 5′-GTCAAGGAGCTGCAGGAGAT-3′; NFKBIA reverse, 5′-CCATGGTCAGTGCCTTTTC T-3′; TNF forward, 5′-CTGCTGCACTT TGGAGTGAT-3′; TNF reverse, 5′-AGATGATCTG ACTGCCTGGG-3′; IL1B forward, 5′-GAAGCTGATGGCCCTAAACA-3′; L1B reverse, 5′-AAGCCCTT GCTGTAGTGGTG-3′; GAPDH forward, 5′-GACTCATGACCACAG TCCATGC-3′; GAPDH reverse, 3′-AGAGGCAGGGATGATGTTCTG-5′. Gene expression data were normalized to the geometric mean of the GAPDH housekeeping gene to control for variability in expression levels and calculated as 2 −[(Ct of gene) − (Ct of GAPDH)] , where C t represents the threshold cycle for each transcript. Quantitation of miRNA was based on the threshold cycle (C t ), and relative expression was calculated as 2 −[(Ct of miR-451) − (Ct of U6)] after normalization to the U6 small nuclear RNA.
Plasmid, small interfering RNA and transfection
The human miR-451 gene was PCR-amplified from genomic DNA and cloned into a pMSCV-puro retroviral vector. The miR-451 antisense (miR-451-RNAi) was cloned into pSuper-retro vector (RNAi-Vector). pNFκB-luc and control plasmids (Clontech, Mountain View, CA) were used to quantitatively examine NF-κB activity. The region of the human IKBKB 3′UTR, from 127 to 712, was PCR-amplified from genomic DNA from HepG2 cells and cloned into pEGFP-C1 (Clontech) and pGL3 (Promega, Madison, WI) vectors. Primers used were IKBKB-3′UTR-GFP forward, 5′-GCCCTCGAGCTTGATCTCACATGG TGGTT CCTG-3′; IKBKB-3′UTR-GFP reverse, 5′-GCCGGTACCAGTCGCT CTTGGCAG AAA-3′; IKBKB-3′UTR-luc forward, 5′-GCCCCGCGGTCTC ACATGGTGGTTCCTG-3′; IKBKB-3′UTR-luc reverse, 5′-GCCCTGCA GAGTCGCTCTTGGCAGAAA-3′;
IKBKB-3′UTR-MUT-luc forward, 5′-GAAAAGTGCTTGGAGTACGGAATGCCACA CACGTGACTGG-3′; IKBKB-3′UTR-MUT-luc reverse, 5′-CCAGTCACGTGTGTGGCATT CCGT ACTCCAAGCACTTTTC-3′. miR-451 mimic oligonucleotides, miR-451 inhibitor (a cholesterol-conjugated 2′-O-Me-modified antisense oligonucleotide designed specifically to bind to and inhibit endogenous miR-486 molecule) and small interfering RNA (siRNA) for depletion of IKBKB was synthesized and purified by RiboBio (Guangzhou, Guangdong, China). The IKBKB siRNA sequences used were IKBKB siRNA#1, 5′-CGCAAGGAGAACAGAGGUUAAU-3′; IKBKB siRNA#2, 5′CGGUGCCUUUGCUAUGAAUUAA-3′. Transfection of miRNA, siRNAs and plasmids was performed using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instruction.
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay
Cells (2 × 10 3 ) were seeded into 96 well plates and stained at the indicated time point with 100 μl sterile 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; Sigma, St Louis, MO) dye (at 0.5 mg/ml) for 4 h at 37°C, followed by removal of the culture medium and the addition of 150 μl dimethyl sulfoxide (Sigma). The absorbance was measured at 570 nm, with 655 nm used as the reference wavelength. All experiments were performed in triplicate. Trypsinized cells (2 × 10 3 ) were suspended in 2 ml complete medium plus 0.3% agar (Sigma). The agar-cell mixture was plated as a top layer onto a bottom layer comprising 1% complete medium agar mixture. After 10 days culture, colony size was measured using an ocular micrometer and colonies >0.1 mm in diameter were counted. The experiment was performed on three independent occasions for each cell line.
Anchorage-independent growth ability (soft agar) assay
Colony formation assay Cells (0.5 × 10
3 ) were plated into six well plates and cultured for 10 days. Colonies were then fixed for 5 min with 10% formaldehyde and stained with 1.0% crystal violet for 30 s.
Bromodeoxyuridine labeling and immunofluorescence
) grown on coverslips (Fisher, Pittsburgh, PA) were incubated with bromodeoxyuridine for 1 h and then labeled with an anti-bromodeoxyuridine antibody (Upstate, Temecula, CA) according to the manufacturer's instruction. Grayscale images were acquired using a laser scanning microscope (Axioskop 2 plus, Carl Zeiss, Jena, Germany). Luciferase reporter assay Cells (5 × 10 5 ) were seeded in triplicate wells in six well plates and allowed to settle for 12 h. One hundred nanograms of pNF-κB luciferase plasmid or control-luciferase plasmid plus 10 ng pRL-TK renilla plasmid (Promega) were transfected into HCC cells using the Lipofectamine 2000 reagent (Invitrogen). Culture medium was replaced after 6 h, and luciferase and renilla signals were measured 48 h after transfection using the Dual Luciferase Reporter Assay Kit (Promega), according to the manufacturer's protocol. Three independent experiments were performed and data are presented as the mean ± SD.
Flow cytometry analysis Cells (0.5 × 10 4 ) were harvested by trypsinization, washed in ice-cold phosphate-buffered saline and fixed in 80% ice-cold ethanol in phosphate-buffered saline. Before staining, cells were gently sedimented and resuspended in cold phosphate-buffered saline. Bovine pancreatic ribonuclease (Sigma-Aldrich) 
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was added to a final concentration of 2 μg/ml, and cells were incubated at 37°C for 30 min, followed by incubation with 20 μg/ml propidium iodide (Sigma-Aldrich) for 20 min at room temperature. Cell samples (5 × 10 5 ) were then analyzed by a FACSCalibur flow cytometer (BD Biosciences).
Statistical analysis
The Student's t-test was used to evaluate significant differences between two groups of data in all relevant experiments. A P value <0.05 (using a two-tailed paired t-test) was taken to indicate significant differences between two data sets.
Results
miR-451 is downregulated in HCC cell lines and clinical tissues
By analysis of a published microarray-based high-throughput assessment, we found that miR-451 expression is significantly lower in HCC tissues than in matched non-cancerous liver tissue (n = 166; P < 0.001; NCBI/GEO/GSE31384; Figure 1A ). Furthermore, real-time PCR assay showed that the miR-451 was markedly downregulated in all eight HCC cell lines examined, including BEL-7402, HCCC-9810, Hep3B, HepG2, HuH7, MHCC97-L, MHCC97-H and QGY-7703, compared with expression in the immortalized normal liver epithelial THLE3 cells ( Figure 1B) . Moreover, comparative analysis indicated that miR-451 was downregulated in eight tumor tissue samples compared with adjacent non-cancerous tissues from the same patient ( Figure 1C) . Collectively, these results suggest that miR-451 is downregulated in HCC.
Ectopically expressed miR-451 inhibits HCC cell proliferation
To determine whether miR-451 plays a role in the development and progression of HCC, we examined the effect of miR-451 Figure 2D ). Importantly, the tumors formed by miR-451-transduced HCC cells were smaller and had lower tumor weights than control tumors ( Figure 2E and F) . Taken together, these results indicate that overexpression of miR-451 reduces the tumorigenicity of HCC cells both in vivo and in vitro.
miR-451 upregulation induces G 1 /S arrest in HCC cells
To explore the mechanism of miR-451-mediated HCC cell growth suppression, we analyzed bromodeoxyuridine (5-bromo-2′-deoxyuridine) (BrdU) incorporation following miR-451 upregulation. As shown in Figure 3A and Supplementary Figure 1D, Figure 3B ). Consistently, we found that the level of retinoblastoma protein phosphorylation was also dramatically decreased in miR-451-overexpressing cells ( Figure 3C ). Collectively, these results suggest that miR-451 overexpression results in the G 1 /S arrest of HCC cells. 
miR-451 inhibits cell proliferation in HCC miR-451 overexpression inhibits NF-κB signaling
Western blotting and real-time reverse transcription-polymerase chain reaction analysis revealed that miR-451 overexpression results in downregulation of the cyclin-dependent kinase regulators, cyclin D1 and c-Myc, which are the key regulators of the G 1 -S transition (23, 24) , at both the protein and mRNA levels ( Figure 3C and D) . Since cyclin D1 and c-Myc are established downstream targets of the NF-κB pathway (25-27), we then examined the effect of overexpressing miR-451 on NF-κB activity. As shown in Figure 4A and B and Supplementary Figure 2A and B, available at Carcinogenesis Online, NF-κB reporter activity and the expression of six classical NF-κB target genes were significantly decreased in miR-451-transfected QGY-7703, HepG2 and Hep3B HCC cells. Since NF-κB activation depends on its cytoplasmic-nuclear transition, we next examined whether miR-451 overexpression affects NF-κB nuclear translocation. Immunofluorescence staining assay showed that miR-451-overexpressing cells exhibit a marked increase in cytoplasmic p65, which was confirmed by cell fractionation assays ( Figure 4C and  D) . These combined data suggest that miR-451 overexpression inactivates NF-κB signaling by inhibiting its nuclear translocation.
mi-451 inhibition promotes HCC cell proliferation
We next examined the effect of miR-451 inhibition on HCC cell proliferation. MTT assay revealed that the growth rates of both HepG2 and QGY-7703 HCC cells transfected miR-451 inhibitor were significantly higher by ~ 2-fold as compared with the control cells at day 4 after plating (Supplementary Figure 3A and B, available at Carcinogenesis Online). Colony formation assay showed that inhibition of miR-451 significantly increased the growth rate of both HepG2 and QGY-7703 HCC cells, up to 3.5-fold, compared with control cells (Supplementary Figure 3C , available at Carcinogenesis Online). Importantly, soft agar assay showed that the anchorage-independent growth ability of HepG2 and QGY-7703 HCC cells was drastically enhanced upon miR-451 transfection, as indicated by increase in colony number on soft agar (Supplementary Figure 3D , available at Carcinogenesis Online). Consistently, the tumors formed by miR-451-downregulated cells were larger, in both size and weight, than the tumors formed by control cells ( Figure 2E ). These results indicate that miR-451 downregulation increased the tumorigenicity of HCC cells in vitro and in vivo. Moreover, BrdU incorporation and flow cytometry assays showed that miR-451 inhibition significantly increased the percentage of S-phase cells and decreased the percentage of G 1 /G 0 -phase cells, thus indicating that miR-451 suppression promotes G 1 /S transition (Supplementary Figure 4A and B, available at Carcinogenesis Online). Taken together, our results demonstrate that miR-451 downregulation plays an important role in the proliferation of HCC cells.
mi-451 inhibition activates NF-κB pathway
As expected, inhibition of miR-451 significantly increased the NF-κB reporter activity and the expression of NF-κB downstream target genes, including cyclin D1 and c-Myc ( Figure 5A and B) , indicating that NF-κB signaling is induced by miR-451 inhibition in HCC cells. Blockage of NF-κB signaling by transfection with an IκBα dominant-negative mutant (IκBα-mu) significantly reduced the percentage of BrdU-positive cells in miR-451-inhibited cells ( Figure 5C ). Importantly, the stimulatory effect of miR-451 downregulation on HCC cell G 1 /S transition was drastically inhibited in following IκBα-mu transfection ( Figure 5D ). Collectively, these results indicate that functional NF-κB activation is critical for miR-451-mediated growth suppression in HCC cells.
miR-451 directly targets IKK-β in HCC cells
Analysis using publicly available algorithms (TargetScan, PicTar and miRanda) predicted that IKK-β, the key activator on NF-κB pathway (28) , is a potential target of miR-451 ( Figure 6A ). As Figure 5A , available at Carcinogenesis Online). To examine whether miR-451-mediated IKK-β downregulation occurs through a miR-451-binding site located in the IKBKB 3′UTR, we subcloned the IKBKB 3′UTR into the pEGFP-C3 and pGL3 dual luciferase reporter vectors. We found that ectopic expression of miR-451 resulted in downregulation of a green fluorescent protein (GFP) reporter containing the IKBKB 3′UTR, but had no effect on expression of a GFP-γ-tubulin reporter ( Figure 6C ), indicating that miR-451 specifically targets the IKBKB 3′UTR. Furthermore, overexpression of miR-451 reduced, but inhibition of miR-451 increased, the luciferase reporter activity of IKBKB 3′UTR in a consistent and dose-dependent manner. However, the activity of an IKBKB 3′UTR luciferase reporter containing point mutations in the miR-451-binding seed region was unaffected by miR-451 overexpression ( Figure 6D and Supplementary Figure 5B , available at Carcinogenesis Online). Collectively, these results demonstrate that IKK-β is a bona fide target of miR-451.
Downregulation of IKK-β is critical for miR-451-mediated NF-κB inactivation
To further investigate the role of IKK-β in miR-451-mediated NF-κB inactivation, we examined the effects of IKK-β downregulation on NF-κB activity in HCC cells. As expected, IKK-β knockdown by two specific IKK-β siRNAs significantly decreased NF-κB luciferase reporter activity ( Figure 6E ). However, miR-451 inhibition in IKK-β-silenced cells did not further reduce the NF-κB luciferase reporter activity ( Figure 6E ). Importantly, NF-κB activation following miR-451 inhibition was abolished by IKK-β downregulation ( Figure 6F ). Taken together, our results demonstrate that IKK-β is an important mediator of NF-κB activation in response to miR-451 inhibition.
Discussion
This study presents the important finding that miR-451 expression is markedly downregulated in HCC cells and clinical tissues compared with levels in THLE3 cells and adjacent non-cancerous tissues from the same patient. We found that miR-451 upregulation inhibits the proliferation and anchorage-independent growth of HCC cells, whereas miR-451 downregulation has the opposite effects. Furthermore, we demonstrated that miR-451 overexpression in HCC cells inhibited the NF-κB pathway through directly targeting the IKBKB 3′UTR. These findings suggest that miR-451 may play an important role in the proliferation of HCC cells by controlling IKK-β-dependent NF-κB signaling.
HCC is a highly malignant tumor that leads > 695 000 deaths worldwide each year (1). It frequently develops in patients who are infected with hepatitis B or C virus (2, 3) . Chronic infection triggers inflammatory cell infiltration and hepatocyte death. These continuing processes result in long-lasting repair and tissue regeneration and eventually lead to cirrhosis, which is a major risk factor for the development of HCC. Although the precise mechanisms are not fully understood, multiple signaling pathways are thought to make important contributions to HCC progression (29) .
The NF-κB signaling pathway plays a critical role in regulating the immune response to infection, and deregulation of this pathway has been linked to inflammatory disease and cancer development (30) . The IKK complex is a direct upstream activator of NF-κB, comprising three important subunits: the catalytic subunits IKK-α and IKK-β (also called IKK1 and IKK2, respectively) and the regulatory subunit IKK-γ (also called NF-kappa-B essential modulator) (31) . IKK-dependent NF-κB signaling is activated during liver injury and inflammation and has been studied extensively in mouse models of liver carcinogenesis (30, 32) . In clinical studies, constitutive NF-κB activation has also been frequently observed in tumor tissues (8) . High levels of expression of IKK-α and IKK-β, the critical kinases for NF-κB activation, is necessary to promote the malignant properties of liver cancer (33) . Compared with IKK-α and IKK-γ, the role of IKK-β is more important for the production of proinflammatory cytokines related to cell survival and cell proliferation (34) . Recent studies suggest that IKK-β/NF-κB activation controls the development of liver metastasis through interleukin-6 expression, which is associated with tumor cell proliferation and angiogenesis (35) . IKK-β deletion was observed to accelerate HCC development and enhance tumor cell proliferation (36) . Collectively, these studies suggest that IKK-dependent NF-κB signaling is linked to HCC and may therefore serve as the target for a therapeutic intervention strategy for HCC. miRNAs are evolutionarily conserved regulatory non-coding RNAs that play critical roles in gene regulation (11, 12) . They mainly regulate target gene expression by promoting mRNAs degradation or repressing protein translation through binding to the 3′UTRs of target mRNAs (12) . Recent advances in cancer biology have implicated changes to miRNA expression as an important mechanism controlling cell proliferation in HCC (37) (38) (39) . Wang et al. (37) reported that miR-138 can induce cell cycle arrest by direct targeting cyclin D3 in HCC cell lines, whereas miR-520b was reported to inhibit the growth of hepatoma cells by targeting MAP3K2 and cyclin D1 (38) . Using a lentiviral vector, Jia et al. (39) found that miR-199a overexpression inhibits cell proliferation in vitro and in vivo, partly through HIF-α downregulation, in human HCC. Thus, an important role for miRNAs in promoting HCC emphasizes their value as new therapeutic targets. In this study, we found that miR-451 was markedly downregulated in HCC cell lines relative to THLE3 cells. In addition, miR-451 expression was downregulated in HCC tissues compared with adjacent non-cancerous tissues from the same patient. Furthermore, we demonstrated that ectopic miR-451 significantly decreases the growth rate of HepG2 and QGY-7703 cells, while miR-451 inhibition promotes cell proliferation and colony formation on soft agar. These data suggest that miR-451 downregulation may enhance HCC cell growth and the development of HCC. To our knowledge, this is the first time this mechanism has been reported for HCC. In fact, upregulation of miR-451, which has an important role in erythropoiesis (40, 41) , has been observed in several different types of cancers. Godlewski et al. (42) showed that miR-451 is downregulated in glioma cells and that miR-451 controls glioma cell proliferation through regulating the LKB1/AMPK signaling pathway. In addition, Bandres et al. (43) demonstrated that miR-451 has a tumor suppression function in gastrointestinal cancer; these experiments documented a lower expression of miR-451 in gastric cancers with a poor prognosis. Wang et al. (44) reported that miR-451 is downregulated in non-small-cell lung carcinoma tissues and that low miR-451 expression correlates with reduced overall survival of non-small-cell lung carcinoma patients. miR-451 downregulation is also reported to be associated with metastasis and poor prognosis in clear cell renal cell carcinoma (45) . Moreover, Bitarte et al. (46) reported that miR-451 is involved in the self-renewal, tumorigenicity and chemoresistance of colorectal cancer stem cells. These published data are consistent with our results that miR-451 plays a tumor suppressor role in cancer cells.
Little was previously known about the molecular mechanism of miR-451 suppression of HCC cell growth. Therefore, we investigated miR-451 function through identifying its target genes. Using bioinformatics analysis, IKK-β was predicted to be a potential direct target of miR-451. We therefore deduced that miR-451 may function through interacting with the IKK-dependent NF-κB signaling pathway. To experimentally validate this hypothesis, we looked for a correlation between miR-451 expression levels, NF-κB signaling and IKK-β expression. We demonstrated that IKK-β is a bona fide miR-451 target that plays a key role in miR-451-activated NF-κB signaling. To our knowledge, this is the first report of this mechanism in HCC. However, it was reported that miR-451 modulates proliferation of glioma cells through regulating LKB1/AMPK signaling pathway (47) . In non-small-cell lung carcinoma cells, ectopic miR-451 expression significantly suppresses in vitro proliferation and colony formation, and the development of tumors in nude mice by enhancing apoptosis, which is associated with inactivation of Akt signaling partly through downregulation of RAB14 (44) . However, we did not observe obvious changes in CAB39 (a direct target of miR-451) or RAB14 expression in HCC cells transfected with miR-451 (data not shown), suggesting that a single miRNA may regulate distinct downstream targets in different cell types. In HCC cells, our findings clearly show that miR-451 inhibits cell proliferation through direct suppression of the IKK-β-dependent classical NF-κB signaling pathway. However, neither miRNAs nor signaling pathways act in isolation and are engaged in extensive cross talk. For example, Zhou et al. (48) found that miR-301a, which plays an important role in increasing proliferation, migration and invasion in HCC cells, modulates NF-κB expression by negatively regulating MEOX2. Furthermore, the NF-κB pathway also activates miR-224 expression and affects HCC cell migration and invasion (49) . As a result, we deduce that miR-451 may interact with many other target pathways in addition to the NF-κB. Moreover, whether other miR-451-regulated signaling pathways play a predominant role in HCC cell proliferation is unclear. Further studies are necessary to define these complex mechanisms, and the application of miR-451 mimics to downregulate the IKK-β-dependent classical NF-κB signaling pathway in HCC patients has a long way to go.
In conclusion, our results suggest that miR-451 acts as a tumor suppressor in HCC cells. Moreover, miR-451 overexpression inhibits cell proliferation by inhibiting the NF-κB signaling pathway through the direct suppression of IKK-β. Further exploration of the molecular link between miR-451 and the NF-κB pathway will increase our understanding of the intricate molecular regulation of HCC cells and may provide novel targets for anticancer therapy. Supplementary Figures 1-5 
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